RU2017129700A3 - - Google Patents

Download PDF

Info

Publication number
RU2017129700A3
RU2017129700A3 RU2017129700A RU2017129700A RU2017129700A3 RU 2017129700 A3 RU2017129700 A3 RU 2017129700A3 RU 2017129700 A RU2017129700 A RU 2017129700A RU 2017129700 A RU2017129700 A RU 2017129700A RU 2017129700 A3 RU2017129700 A3 RU 2017129700A3
Authority
RU
Russia
Application number
RU2017129700A
Other languages
Russian (ru)
Other versions
RU2017129700A (ru
RU2776110C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2011905368A external-priority patent/AU2011905368A0/en
Application filed filed Critical
Publication of RU2017129700A publication Critical patent/RU2017129700A/ru
Publication of RU2017129700A3 publication Critical patent/RU2017129700A3/ru
Application granted granted Critical
Publication of RU2776110C2 publication Critical patent/RU2776110C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
RU2017129700A 2012-11-02 Схема дозирования для составов аполипопротеина RU2776110C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2011905368 2011-12-21
AU2011905368A AU2011905368A0 (en) 2011-12-21 Dosing regime for apolipoprotein formulations

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2014129505A Division RU2014129505A (ru) 2011-12-21 2012-11-02 Схема дозирования для составов аполипопротеина

Publications (3)

Publication Number Publication Date
RU2017129700A RU2017129700A (ru) 2019-02-04
RU2017129700A3 true RU2017129700A3 (enExample) 2021-02-26
RU2776110C2 RU2776110C2 (ru) 2022-07-13

Family

ID=

Also Published As

Publication number Publication date
KR20200037879A (ko) 2020-04-09
BR112014014403A8 (pt) 2021-03-09
AU2012310259A1 (en) 2013-07-11
JP2015500840A (ja) 2015-01-08
KR102766038B1 (ko) 2025-02-12
MX2014006589A (es) 2014-10-17
AU2012310259C1 (en) 2016-07-14
RU2014129505A (ru) 2016-02-10
HK1199813A1 (en) 2015-07-24
JP2017128586A (ja) 2017-07-27
EP2793913A1 (en) 2014-10-29
PL2793913T3 (pl) 2023-11-06
RU2017129700A (ru) 2019-02-04
US20160175392A1 (en) 2016-06-23
US20140378376A1 (en) 2014-12-25
BR112014014403A2 (pt) 2017-06-13
US20240216467A1 (en) 2024-07-04
DK2793913T3 (da) 2023-08-21
EP2793913B1 (en) 2023-06-21
CN104010646A (zh) 2014-08-27
EP2793913A4 (en) 2015-06-10
NZ624558A (en) 2015-08-28
WO2013090978A1 (en) 2013-06-27
JP6144276B2 (ja) 2017-06-07
SG11201402556RA (en) 2014-10-30
KR20140107536A (ko) 2014-09-04
KR20190084334A (ko) 2019-07-16
MX377093B (es) 2025-03-07
CN113398245A (zh) 2021-09-17
AU2012310259B2 (en) 2015-07-30
CA2857968A1 (en) 2013-06-27
IL233236A0 (en) 2014-08-31
ES2955110T3 (es) 2023-11-28

Similar Documents

Publication Publication Date Title
BR112013022641A2 (enExample)
BR112013024383A2 (enExample)
BR112013023185A2 (enExample)
BR112013022995A2 (enExample)
BR112013026905A2 (enExample)
BR112013017670A2 (enExample)
AP3853A (enExample)
BR112013026744A2 (enExample)
BR112013023927A2 (enExample)
BR112013024365A2 (enExample)
BR112013028733A2 (enExample)
BR112013024588A2 (enExample)
BR112013031556A2 (enExample)
BR112013026790A2 (enExample)
BR112013032366A2 (enExample)
BR112013032377A2 (enExample)
BR112013032380A2 (enExample)
BR112013018949A2 (enExample)
BR112013026895A2 (enExample)
BR112013021637A2 (enExample)
BR112013023266A2 (enExample)
BR112013032392A2 (enExample)
BR112013025487A2 (enExample)
BR112013017878A2 (enExample)
BR112013032394A2 (enExample)